Biotech for less than cash value Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than cash value

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Hank who wrote (188)	8/10/2003 6:09:45 PM
From: AuBug	Read Replies (1) of 684

Hank, I believe the journal Immunology Today does an annual review of all therapeutic mAbs approved by the FDA and pending. I haven't seen the latest review and I was unable to access it from home. When I go to work tomorrow I'll look it up. If they haven't submitted a mAb discovered using phage display techniques it's inevitable that they will. Some high powered folks are working on it hard, e.g. Dennis Burton & Carlos Barbas at Scripps Institute: scripps.edu scripps.edu

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next